Discover
LFCR
Lifecore Biomedical, Inc.
4.64
20 x 4.50
1 x 6.61
bid
ask
+
0.00
0.00%
1 @ 08:58 AM
4.79 +0.15 (3.23%)
| Ytd | -43.28% | |
| 1y | -37.63% |
day range
3.63
52 week range
8.98
| Open | Prev Close | 4.64 | Low | High | Mkt Cap | 174.04M | |||
| Vol | 0.00 | Avg Vol | 206.58K | EPS | -0.98 | P/E | -4.73 | Forward P/E | -9.90 |
| Beta | 1.06 | Short Ratio | 11.20 | Inst. Own | 69.84% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 5.06 | 200-d Avg | 6.34 | 1yr Est | 8.00 |
| Income Statement | |||
| Total Revenue | 23.19M | ||
| Revenues (USD) | 23.19M | ||
| Cost of Revenue | 18.73M | ||
| Gross Profit | 4.46M | ||
| Operating Expenses | 9.13M | ||
| Research and Development Expense | 1.22M | ||
| Selling, General and Administrative Expense | 7.92M | ||
| Operating Income | -4.67M | ||
| Interest Expense | 7.35M | ||
| Income Tax Expense | 43.00K | ||
| Net Income | -14.98M | ||
| Net Income Common Stock | -15.93M | ||
| Net Income Common Stock (USD) | -15.93M | ||
| Consolidated Income | -14.98M | ||
| Earnings per Basic Share | -0.43 | ||
| Earnings per Basic Share (USD) | -0.43 | ||
| Earnings per Diluted Share | -0.43 | ||
| Earning Before Interest & Taxes (EBIT) | -7.59M | ||
| Earning Before Interest & Taxes (USD) | -7.59M | ||
| Preferred Dividends Income Statement Impact | 954.00K | ||
| Weighted Average Shares | 37.48M | ||
| Weighted Average Shares Diluted | 37.48M | ||
| Balance Sheet | |||
| Cash and Equivalents | 20.80M | ||
| Cash and Equivalents (USD) | 20.80M | ||
| Trade and Non-Trade Receivables | 19.44M | ||
| Current Assets | 77.64M | ||
| Property, Plant & Equipment Net | 125.51M | ||
| Total Assets | 225.50M | ||
| Total Debt | 147.78M | ||
| Current Liabilities | 20.50M | ||
| Debt Non-Current | 147.78M | ||
| Total Liabilities | 204.72M | ||
| Accumulated Retained Earnings (Deficit) | -238.18M | ||
| Shareholders Equity | -28.44M | ||
| Shareholders Equity (USD) | -28.44M | ||
| Assets Non-Current | 147.86M | ||
| Total Debt (USD) | 147.78M | ||
| Goodwill and Intangible Assets | 13.88M | ||
| Inventory | 28.16M | ||
| Liabilities Non-Current | 184.22M | ||
| Trade and Non-Trade Payables | 7.01M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.31M | ||
| Net Cash Flow from Financing | -256.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.33M | ||
| Capital Expenditure | -1.12M | ||
| Net Cash Flow from Investing | -1.12M | ||
| Net Cash Flow from Operations | 4.70M | ||
| Share Based Compensation | 1.70M | ||